A phase 3 trial of Fluorouracil, Leucovorin and Raltitrexed in Colorectal cancer, run by Medical Research Council, with a status the registry has not verified recently.
Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer is a phase 3 interventional study registered as NCT00002893 by Medical Research Council, with 900 participants planned, started 1995-06. Interventions recorded: fluorouracil, leucovorin calcium, raltitrexed. Conditions recorded: Colorectal Cancer.
Linked to the drug Raltitrexed because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Raltitrexed and the tag pipeline.
Shares Raltitrexed and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/